Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,380.34
(
-1.49%
)
US TECH 100
22,557.20
(
-1.72%
)
Dow Jones
45,227.67
(
-1.59%
)
Brent Oil
105.46
(
4.76%
)
Bitcoin
65,786.06
(
-4.36%
)
News Focus
News Focus
Post# of 257295
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

swampboots

Send PM Follow Ignore
Followers 179
Posts 30024
Boards Moderated 3
Alias Born 07/09/2003

swampboots

Re: DewDiligence post# 24488

Thursday, 02/23/2006 9:25:40 AM

Thursday, February 23, 2006 9:25:40 AM

Post# of 257295
DEW, re:GTCB and insufficient patients, testing, and data uh are you saying the endpoint probability as to whether stuff works is open to better testing design and that scope of presentation (grab bag of flawed elements) sabatoged the project before a scientific basis for the drug could be properly analyised?

Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today